-+ 0.00%
-+ 0.00%
-+ 0.00%

ST Huluwa (605199.SH) obtained drug registration certificate for levosalbutamol hydrochloride atomized inhalation solution

Zhitongcaijing·01/05/2026 14:09:11
Listen to the news

Zhitong Finance App News, ST Huluwa (605199.SH) issued an announcement. The company recently received the “Drug Registration Certificate” for levosalbutamol hydrochloride atomized inhalation solution approved and issued by the State Drug Administration (“State Drug Administration”). Levosalbutamol hydrochloride nebulized inhalation solution is suitable for treating or preventing bronchospasm caused by reversible airway obstructive diseases in adults and children over 6 years of age.